Can a patient on tadalafil (PDE5 inhibitor) 5 mg once daily add vardenafil (PDE5 inhibitor) to their regimen without nitrates?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Do Not Add Vardenafil to Tadalafil 5 mg Daily

You should not prescribe vardenafil on top of tadalafil 5 mg once daily—this combination is not supported by evidence and creates unnecessary risk without proven benefit. 1, 2

Why Combining PDE5 Inhibitors Is Not Recommended

There is no evidence supporting the concurrent use of two different PDE5 inhibitors. 1 The American Urological Association guidelines explicitly state that PDE5 inhibitors should be used as monotherapy, and clinical trials have never evaluated the safety or efficacy of combining different PDE5 inhibitors. 1

  • All three PDE5 inhibitors (sildenafil, tadalafil, vardenafil) have similar efficacy and adverse event profiles, with no superiority of one agent over another. 1
  • Combining PDE5 inhibitors would increase the risk of adverse effects (headache, flushing, hypotension, dyspepsia) without evidence of improved erectile function. 1
  • Studies comparing PDE5 inhibitors plus non-PDE5 inhibitors versus PDE5 inhibitors alone showed increased adverse events with combination therapy. 1

The Correct Approach: Switch, Don't Stack

If tadalafil 5 mg daily is inadequate, you should switch to a different PDE5 inhibitor rather than adding one. 1, 2

Before switching, ensure the current trial is adequate:

  • Verify the patient has taken tadalafil for at least 4-8 doses (adequate trial duration). 1
  • Confirm proper timing and sexual stimulation are occurring. 1
  • Rule out modifiable factors: hormonal abnormalities, heavy alcohol use, relationship issues, inadequate sexual stimulation. 1
  • Ensure the patient understands that daily tadalafil provides continuous coverage and doesn't require timing with sexual activity. 3

If switching from tadalafil to vardenafil:

  • No mandatory waiting period is required when switching between PDE5 inhibitors. 2
  • Simply discontinue tadalafil and start vardenafil at the appropriate dose (typically 10 mg, taken 1 hour before sexual activity). 2, 4
  • Vardenafil has a shorter duration of action (4-5 hours) compared to tadalafil (up to 36 hours), which some patients may prefer or find less effective. 2, 5, 4

Critical Safety Consideration: Nitrate Interaction

The primary concern with any PDE5 inhibitor regimen is the absolute contraindication with nitrates. 1, 2, 6

Timing requirements if nitrates become necessary:

  • After tadalafil use: wait at least 48 hours before administering any nitrate. 1, 2, 6
  • After vardenafil use: wait at least 24 hours before administering nitrates. 1, 2
  • The combination of PDE5 inhibitors with nitrates can cause profound hypotension, myocardial infarction, and death. 1, 2, 6

Documentation is critical:

  • Always document which PDE5 inhibitor the patient is taking and when it was last taken, particularly important for emergency situations where nitrates might be needed. 2, 6
  • Counsel the patient that if they develop chest pain requiring emergency care, they must inform providers about their PDE5 inhibitor use. 6

Common Pitfall to Avoid

Do not assume that because the patient is on a low daily dose of tadalafil (5 mg), adding vardenafil "as needed" would be safe or effective. This approach:

  • Lacks any evidence base. 1
  • Increases adverse event risk unnecessarily. 1
  • Complicates the nitrate contraindication timeline (would need to wait 48 hours from last tadalafil dose). 1, 2, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Contraindications and Precautions for Nitro-BID Ointment and Tadalafil

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.